AstraZeneca COVID vaccine under USFDA safety inquiry Ruchika Sharma2 Oct 2020 10:30 AM ISTWashington: The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's Covid-19 vaccine study and...
Serum Institute gets DCGI nod to restart Oxford Vaccine trial with certain conditions Ruchika Sharma17 Sept 2020 11:37 AM ISTDSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain...
AstraZeneca COVID-19 vaccine trial pause applauded by WHO Ruchika Sharma15 Sept 2020 9:30 AM ISTGeneva: A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus...
AstraZeneca restarts COVID-19 vaccine trials in UK Ruchika Sharma14 Sept 2020 1:00 PM ISTIt added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.
AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO Ruchika Sharma11 Sept 2020 1:04 PM ISTThe trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator Ruchika Sharma11 Sept 2020 8:45 AM ISTUK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
AstraZeneca halts COVID19 vaccine trial after recipient unexplained illness Ruchika Sharma9 Sept 2020 1:05 PM ISTNew York: Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sept 2020 9:15 AM ISTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
AstraZeneca diabetes drug dapagliflozin shows significant benefits in CKD patients Ruchika Sharma3 Sept 2020 3:33 PM ISTBangalore: AstraZeneca India has announced the full results from the clinical trials of it's latest diabetes drug, dapagliflozin, showing...
